← FDA Drug Approvals (Drugs@FDA)
NEXTSTELLIS
NDA · New Drug Application · Sponsor: MAYNE PHARMA · Approved 2021-04-15
Drug application
- FDA Application #
NDA214154- Application type
- New Drug Application
- Brand name
- NEXTSTELLIS
- Generic name
- DROSPIRENONE AND ESTETROL
- Active ingredients
- DROSPIRENONE; ESTETROL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MAYNE PHARMA
- Manufacturer
- Mayne Pharma
- First approval
- 2021-04-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown